{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:58:15Z","timestamp":1776117495746,"version":"3.50.1"},"reference-count":187,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:00:00Z","timestamp":1774310400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR078624"],"award-info":[{"award-number":["R01AR078624"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR081882"],"award-info":[{"award-number":["R01AR081882"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR078571"],"award-info":[{"award-number":["R01AR078571"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.addr.2026.115859","type":"journal-article","created":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T07:34:17Z","timestamp":1774078457000},"page":"115859","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Progress on cell therapy for skeletal muscle disorders"],"prefix":"10.1016","volume":"233","author":[{"given":"Karim","family":"Azzag","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita C.R.","family":"Perlingeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2026.115859_bb0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1093\/ajcn\/76.2.378","article-title":"Total-body skeletal muscle mass: estimation by a new dual-energy X-ray absorptiometry method","volume":"76","author":"Kim","year":"2002","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.addr.2026.115859_bb0010","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00223-014-9915-y","article-title":"Skeletal muscle: a brief review of structure and function","volume":"96","author":"Frontera","year":"2015","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.addr.2026.115859_bb0015","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.devcel.2004.05.006","article-title":"A two-step mechanism for myotome formation in chick","volume":"6","author":"Gros","year":"2004","journal-title":"Dev. Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0020","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcdb.2017.11.010","article-title":"The myogenic regulatory factors, determinants of muscle development, cell identity and regeneration","volume":"72","author":"Hern\u00e1ndez-Hern\u00e1ndez","year":"2017","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0025","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1038\/nature03594","article-title":"A Pax3\/Pax7-dependent population of skeletal muscle progenitor cells","volume":"435","author":"Relaix","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0030","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1242\/dev.120.4.957","article-title":"Regulation of Pax-3 expression in the dermomyotome and its role in muscle development","volume":"120","author":"Goulding","year":"1994","journal-title":"Development"},{"key":"10.1016\/j.addr.2026.115859_bb0035","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0092-8674(00)80189-0","article-title":"Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD","volume":"89","author":"Tajbakhsh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000897","article-title":"A Pax3\/Dmrt2\/Myf5 regulatory cascade functions at the onset of myogenesis","volume":"6","author":"Sato","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.addr.2026.115859_bb0045","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/j.1460-2075.1989.tb03429.x","article-title":"A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1\/2 fibroblasts","volume":"8","author":"Braun","year":"1989","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2026.115859_bb0050","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1101\/gad.3.5.628","article-title":"A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program","volume":"3","author":"Edmondson","year":"1989","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2026.115859_bb0055","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1016\/0092-8674(93)90621-V","article-title":"MyoD or Myf-5 is required for the formation of skeletal muscle","volume":"75","author":"Rudnicki","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0060","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nature02876","article-title":"Mrf4 determines skeletal muscle identity in Myf5: Myod double-mutant mice","volume":"431","author":"Kassar-Duchossoy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0065","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0092-8674(89)90583-7","article-title":"Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD","volume":"56","author":"Wright","year":"1989","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0070","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1073\/pnas.87.3.1089","article-title":"Herculin, a fourth member of the MyoD family of myogenic regulatory genes","volume":"87","author":"Miner","year":"1990","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.addr.2026.115859_bb0075","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1101\/gad.247205.114","article-title":"Myomaker is essential for muscle regeneration","volume":"28","author":"Millay","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.addr.2026.115859_bb0080","doi-asserted-by":"crossref","first-page":"17272","DOI":"10.1074\/jbc.M117.811372","article-title":"Insights into the localization and function of myomaker during myoblast fusion","volume":"292","author":"Gamage","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2026.115859_bb0085","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nature12343","article-title":"Myomaker is a membrane activator of myoblast fusion and muscle formation","volume":"499","author":"Millay","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0090","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15665","article-title":"Myomerger induces fusion of non-fusogenic cells and is required for skeletal muscle development","volume":"8","author":"Quinn","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0095","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.tcb.2019.09.002","article-title":"Cell fusion: merging membranes and making muscle","volume":"29","author":"Petrany","year":"2019","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0100","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1083\/jcb.9.2.493","article-title":"Satellite cell of skeletal muscle fibers","volume":"9","author":"Mauro","year":"1961","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0105","series-title":"Satellite cells in human skeletal muscle; from birth to old age","first-page":"545","volume":"36","author":"Verdijk","year":"2014"},{"key":"10.1016\/j.addr.2026.115859_bb0110","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1083\/jcb.44.2.459","article-title":"Nature of dividing nuclei in skeletal muscle of growing rats","volume":"44","author":"Moss","year":"1970","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0115","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1006\/dbio.1999.9565","article-title":"A new look at the origin, function, and \u201cstem-cell\u201d status of muscle satellite cells","volume":"218","author":"Seale","year":"2000","journal-title":"Dev. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0120","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.1038\/sj.emboj.7600346","article-title":"Pax7 directs postnatal renewal and propagation of myogenic satellite cells but not their specification","volume":"23","author":"Oustanina","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.addr.2026.115859_bb0125","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1083\/jcb.111.1.201","article-title":"Cell cycle commitment of rat muscle satellite cells","volume":"111","author":"Bischoff","year":"1990","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0130","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13395-020-00237-2","article-title":"Exercise promotes satellite cell contribution to myofibers in a load-dependent manner","volume":"10","author":"Masschelein","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.addr.2026.115859_bb0135","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cell.2005.05.010","article-title":"Stem cell function, self-renewal, and behavioral heterogeneity of cells from the adult muscle satellite cell niche","volume":"122","author":"Collins","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0140","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nature07384","article-title":"Self-renewal and expansion of single transplanted muscle stem cells","volume":"456","author":"Sacco","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0145","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.cell.2007.03.044","article-title":"Asymmetric self-renewal and commitment of satellite stem cells in muscle","volume":"129","author":"Kuang","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0150","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/s41467-020-20760-6","article-title":"Perspectives on skeletal muscle stem cells","volume":"12","author":"Relaix","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/bs.ctdb.2024.01.018","article-title":"The satellite cell in skeletal muscle: a story of heterogeneity","volume":"158","author":"Guilhot","year":"2024","journal-title":"Curr. Top. Dev. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0160","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1083\/jcb.108.5.1873","article-title":"Fibroblasts that proliferate near denervated synaptic sites in skeletal muscle synthesize the adhesive molecules tenascin(J1), N-CAM, fibronectin, and a heparan sulfate proteoglycan","volume":"108","author":"Gatchalian","year":"1989","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0165","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1432-0436.1984.tb00279.x","article-title":"Role of muscle fibroblasts in the deposition of type-IV collagen in the basal lamina of myotubes","volume":"28","author":"K\u00fchl","year":"1984","journal-title":"Differentiation"},{"key":"10.1016\/j.addr.2026.115859_bb0170","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1083\/jcb.102.3.740","article-title":"Fibroblasts promote the formation of a continuous basal lamina during myogenesis in vitro","volume":"102","author":"Sanderson","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0175","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0012-1606(81)80010-3","article-title":"Origin of collagen types I, III, and V in cultures of avian skeletal muscle","volume":"83","author":"Sasse","year":"1981","journal-title":"Dev. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0180","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/284470a0","article-title":"A role for collagen in the pathogenesis of muscular dystrophy?","volume":"284","author":"Duance","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0185","doi-asserted-by":"crossref","first-page":"3654","DOI":"10.1242\/jcs.086629","article-title":"Fibrosis and adipogenesis originate from a common mesenchymal progenitor in skeletal muscle","volume":"124","author":"Uezumi","year":"2011","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.addr.2026.115859_bb0190","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ncb2015","article-title":"Muscle injury activates resident fibro\/adipogenic progenitors that facilitate myogenesis","volume":"12","author":"Joe","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0195","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nm.3869","article-title":"Nilotinib reduces muscle fibrosis in chronic muscle injury by promoting TNF-mediated apoptosis of fibro\/adipogenic progenitors","volume":"21","author":"Lemos","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0200","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1038\/s41467-018-06068-6","article-title":"Dynamics of cellular states of fibro-adipogenic progenitors during myogenesis and muscular dystrophy","volume":"9","author":"Malecova","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0205","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3390\/ijms23041983","article-title":"Persistent fibroadipogenic progenitor expansion following transient DUX4 expression provokes a profibrotic state in a mouse model for FSHD","volume":"23","author":"Bosnakovski","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2026.115859_bb0210","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1038\/s41467-019-10438-z","article-title":"Fibroadipogenic progenitors are responsible for muscle loss in limb girdle muscular dystrophy 2B","volume":"10","author":"Hogarth","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0215","first-page":"10","article-title":"The many roles of macrophages in skeletal muscle injury and repair. Front cell","author":"Wang","year":"2022","journal-title":"Dev. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0220","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nri.2016.150","article-title":"Regulation of muscle growth and regeneration by the immune system","volume":"17","author":"Tidball","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2026.115859_bb0225","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0960-8966(94)90068-X","article-title":"Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis","volume":"4","author":"Gorospe","year":"1994","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0230","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0002-9440(10)65050-X","article-title":"Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors","volume":"156","author":"Cai","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2026.115859_bb0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1083\/jcb.200105110","article-title":"A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice","volume":"155","author":"Wehling","year":"2001","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0240","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1006\/clim.2000.4966","article-title":"Helper (CD4+) and cytotoxic (CD8+) T cells promote the pathology of dystrophin-deficient muscle","volume":"98","author":"Spencer","year":"2001","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.addr.2026.115859_bb0245","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.stem.2018.09.007","article-title":"Muscle satellite cell cross-talk with a vascular niche maintains quiescence via VEGF and notch signaling","volume":"23","author":"Verma","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0250","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1161\/CIRCRESAHA.113.300203","article-title":"Pericytes in development and pathology of skeletal muscle","volume":"113","author":"Cappellari","year":"2013","journal-title":"Circ. Res."},{"issue":"7","key":"10.1016\/j.addr.2026.115859_bb0255","first-page":"1242","article-title":"Pericytes in the myovascular niche promote post-natal myofiber growth and satellite cell quiescence","volume":"142","author":"Kostallari","year":"2015","journal-title":"Development"},{"key":"10.1016\/j.addr.2026.115859_bb0260","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/S0140-6736(19)32910-1","article-title":"Muscular dystrophies","volume":"394","author":"Mercuri","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2026.115859_bb0265","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/0092-8674(87)90579-4","article-title":"Dystrophin: the protein product of the Duchenne muscular dystrophy locus","volume":"51","author":"Hoffman","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsb.2019.107411","article-title":"How the central domain of dystrophin acts to bridge F-actin to sarcolemmal lipids","volume":"209","author":"Mias-Lucquin","year":"2020","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.addr.2026.115859_bb0275","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/338259a0","article-title":"Association of dystrophin and an integral membrane glycoprotein","volume":"338","author":"Campbell","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0280","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0285","first-page":"97","article-title":"Life expectancy in Duchenne muscular dystrophy","author":"Broomfield","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115859_bb0290","doi-asserted-by":"crossref","first-page":"00176","DOI":"10.1183\/23120541.00176-2023","article-title":"Cardiomyopathy as cause of death in Duchenne muscular dystrophy: a longitudinal observational study","volume":"9","author":"Lechner","year":"2023","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.addr.2026.115859_bb0295","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1212\/WNL.0000000000000797","article-title":"Population-based incidence and prevalence of facioscapulohumeral dystrophy","volume":"83","author":"Deenen","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115859_bb0300","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1399-0004.2009.01158.x","article-title":"Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample","volume":"75","author":"Mostacciuolo","year":"2009","journal-title":"Clin. Genet."},{"key":"10.1016\/j.addr.2026.115859_bb0305","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1189044","article-title":"A unifying genetic model for Facioscapulohumeral muscular dystrophy","volume":"329","author":"Lemmers","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115859_bb0310","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1038\/s41467-017-00730-1","article-title":"Muscle pathology from stochastic low level DUX4 expression in an FSHD mouse model","volume":"8","author":"Bosnakovski","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0315","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.3390\/jcm12144769","article-title":"Limb\u2013Girdle muscular dystrophies classification and therapies","volume":"12","author":"Bouchard","year":"2023","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0320","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1469-1809.1952.tb02497.x","article-title":"Muscular dystrophy in Northern Ireland I. An account of the condition in fifty-one families","volume":"17","author":"Stevenson","year":"1952","journal-title":"Ann. Eugenics"},{"key":"10.1016\/j.addr.2026.115859_bb0325","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/brain\/77.2.169","article-title":"On the classification, natural history and treatment of the myopathies","volume":"77","author":"Walton","year":"1954","journal-title":"Brain"},{"key":"10.1016\/j.addr.2026.115859_bb0330","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.nmd.2006.09.015","article-title":"Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF","volume":"17","author":"Diers","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0335","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1002\/jcsm.12987","article-title":"Three-year quantitative magnetic resonance imaging and phosphorus magnetic resonance spectroscopy study in lower limb muscle in dysferlinopathy","volume":"13","author":"Reyngoudt","year":"2022","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.addr.2026.115859_bb0340","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1179\/174313209X380847","article-title":"The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B)","volume":"32","author":"Angelini","year":"2010","journal-title":"Neurol. Res."},{"key":"10.1016\/j.addr.2026.115859_bb0345","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0092-8674(95)90368-2","article-title":"Mutations in the proteolytic enzyme calpain 3 cause limb-girdle muscular dystrophy type 2A","volume":"81","author":"Richard","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0350","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.nmd.2008.08.005","article-title":"Calpain 3, the \u201cgatekeeper\u201d of proper sarcomere assembly, turnover and maintenance","volume":"18","author":"Beckmann","year":"2008","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0355","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bbadis.2006.07.002","article-title":"Molecular and cellular basis of calpainopathy (limb girdle muscular dystrophy type 2A)","volume":"1772","author":"Kramerova","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2026.115859_bb0360","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/S0002-9440(10)63551-1","article-title":"Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression","volume":"163","author":"Fanin","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2026.115859_bb0365","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s13311-018-00674-4","article-title":"Diagnosis and treatment of mitochondrial myopathies","volume":"15","author":"Ahmed","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.addr.2026.115859_bb0370","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/ana.24362","article-title":"Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease","volume":"77","author":"Gorman","year":"2015","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0375","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/archneur.63.12.1701","article-title":"Muscle phenotype and mutation load in 51 persons with the 3243A>G mitochondrial DNA mutation","volume":"63","author":"Jeppesen","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0380","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/WCO.0000000000000743","article-title":"Advances in primary mitochondrial myopathies","volume":"32","author":"de Barcelos","year":"2019","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0385","doi-asserted-by":"crossref","first-page":"449","DOI":"10.7326\/0003-4819-148-6-200803180-00210","article-title":"National Institutes of Health state-of-the-science conference statement: prevention of fecal and urinary incontinence in adults","volume":"148","author":"Landefeld","year":"2008","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0390","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/jmwh.12283","article-title":"Obstetric anal sphincter injury and anal incontinence following vaginal birth: a systematic review and meta-analysis","volume":"60","author":"LaCross","year":"2015","journal-title":"J. Midwifery Womens Health"},{"key":"10.1016\/j.addr.2026.115859_bb0395","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1007\/s11605-015-2905-1","article-title":"Fecal incontinence: etiology, diagnosis, and management","volume":"19","author":"Alavi","year":"2015","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.addr.2026.115859_bb0400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0140-6736(06)67925-7","article-title":"Urinary incontinence in women","volume":"367","author":"Norton","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2026.115859_bb0405","first-page":"423","article-title":"Urinary incontinence in women","volume":"77","author":"Goforth","year":"2016","journal-title":"N. C. Med. J."},{"key":"10.1016\/j.addr.2026.115859_bb0410","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/337176a0","article-title":"Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts","volume":"337","author":"Partridge","year":"1989","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0415","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/ana.410340105","article-title":"Myoblast transfer in Duchenne muscular dystrophy","volume":"34","author":"Karpati","year":"1993","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0420","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1056\/NEJM199509283331303","article-title":"Myoblast transfer in the treatment of Duchenne\u2019s muscular dystrophy","volume":"333","author":"Mendell","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0425","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/0140-6736(90)91628-N","article-title":"Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy","volume":"336","author":"Law","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2026.115859_bb0430","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/356435a0","article-title":"Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation","volume":"356","author":"Gussoni","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0435","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/096368979300200203","article-title":"Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy","volume":"2","author":"Tremblay","year":"1993","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0440","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1442-200X.1991.tb01545.x","article-title":"Myoblast transfer therapy for Duchenne muscular dystrophy","volume":"33","author":"Law","year":"1991","journal-title":"Pediatr. Int."},{"key":"10.1016\/j.addr.2026.115859_bb0445","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1042\/cs0810287","article-title":"Correspondence section: myoblast transplantation produced dystrophin-positive muscle fibres in a 16-year-old patient with Duchenne muscular dystrophy","volume":"81","author":"Huard","year":"1991","journal-title":"Clin. Sci."},{"key":"10.1016\/j.addr.2026.115859_bb0450","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.0.CO;2-U","article-title":"Myoblast implantation in Duchenne muscular dystrophy: the San Francisco study","volume":"20","author":"Miller","year":"1997","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.addr.2026.115859_bb0455","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/mus.880150504","article-title":"Human myoblast transplantation: preliminary results of 4 cases","volume":"15","author":"Huard","year":"1992","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.addr.2026.115859_bb0460","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/0963689792001002-305","article-title":"Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys","volume":"1","author":"Law","year":"1992","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0465","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1212\/WNL.43.3_Part_1.527","article-title":"Cyclosporine increases muscular force generation in Duchenne muscular dystrophy","volume":"43","author":"Sharma","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115859_bb0470","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048478","article-title":"Effects of an immunosuppressive treatment in the GRMD dog model of Duchenne muscular dystrophy","volume":"7","author":"Barth\u00e9l\u00e9my","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.addr.2026.115859_bb0475","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ymthe.2003.11.023","article-title":"Dystrophin expression in myofibers of Duchenne muscular dystrophy patients following intramuscular injections of normal myogenic cells","volume":"9","author":"Skuk","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0480","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/01.jnen.0000218443.45782.81","article-title":"Dystrophin expression in muscles of Duchenne muscular dystrophy patients after high-density injections of normal myogenic cells","volume":"65","author":"Skuk","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0485","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nmd.2006.10.003","article-title":"First test of a \u201chigh-density injection\u201d protocol for myogenic cell transplantation throughout large volumes of muscles in a Duchenne muscular dystrophy patient: eighteen months follow-up","volume":"17","author":"Skuk","year":"2007","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0490","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0960-8966(97)00148-X","article-title":"Myoblast transplantation in non-dystrophic dog","volume":"8","author":"Ito","year":"1998","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0495","first-page":"1217","article-title":"Myoblast allotransplantation in primates","volume":"18","author":"Kinoshita","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.addr.2026.115859_bb0500","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3727\/096020198389898","article-title":"Changes in mass and performance in rabbit muscles after muscle damage with or without transplantation of primary satellite cells","volume":"11","author":"Boubaker el Andalousi","year":"2002","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0505","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.nmd.2004.11.001","article-title":"Autologous transplantation of porcine myogenic precursor cells in skeletal muscle","volume":"15","author":"Holzer","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.addr.2026.115859_bb0510","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3727\/096368914X685032","article-title":"First study of intra-arterial delivery of myogenic mononuclear cells to skeletal muscles in primates","volume":"23","author":"Skuk","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0515","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/jnen\/nlaa110","article-title":"Human muscle precursor cells form human-derived myofibers in skeletal muscles of nonhuman primates: a potential new preclinical setting to test myogenic cells of human origin for cell therapy of myopathies","volume":"79","author":"Skuk","year":"2020","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0520","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3727\/096368912X661337","article-title":"Intramuscular transplantation of myogenic cells in primates: importance of needle size, cell number, and injection volume","volume":"23","author":"Skuk","year":"2014","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0525","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1038\/mt.2010.128","article-title":"Intramuscular transplantation of human postnatal myoblasts generates functional donor-derived satellite cells","volume":"18","author":"Skuk","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0530","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.yexcr.2018.02.011","article-title":"Modelling human myoblasts survival upon xenotransplantation into immunodeficient mouse muscle","volume":"364","author":"Praud","year":"2018","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.addr.2026.115859_bb0535","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1038\/mt.2013.186","article-title":"The Rag2\u2013Il2rb\u2013Dmd\u2013 mouse: a novel dystrophic and immunodeficient model to assess innovating therapeutic strategies for muscular dystrophies","volume":"21","author":"Vallese","year":"2013","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0540","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/01.tp.0000288322.94252.22","article-title":"Ischemic central necrosis in pockets of transplanted myoblasts in nonhuman primates: implications for cell-transplantation strategies","volume":"84","author":"Skuk","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.addr.2026.115859_bb0545","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/SLA.0000000000002268","article-title":"Autologous myoblasts for the treatment of fecal incontinence","volume":"267","author":"Boyer","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.addr.2026.115859_bb0550","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s00384-013-1692-y","article-title":"Successful implantation of autologous muscle-derived stem cells in treatment of fecal incontinence due to external sphincter rupture","volume":"28","author":"Michal","year":"2013","journal-title":"Int. J. Color. Dis."},{"key":"10.1016\/j.addr.2026.115859_bb0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gut.2009.181347","article-title":"Muscle-derived cell injection to treat anal incontinence due to obstetric trauma: pilot study with 1 year follow-up","volume":"59","author":"Frudinger","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.addr.2026.115859_bb0560","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s10151-015-1351-0","article-title":"Implantation of autologous muscle-derived stem cells in treatment of fecal incontinence: results of an experimental pilot study","volume":"19","author":"Romaniszyn","year":"2015","journal-title":"Tech. Coloproctol."},{"key":"10.1016\/j.addr.2026.115859_bb0565","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/codi.12947","article-title":"Autologous skeletal-muscle-derived cell injection for anal incontinence due to obstetric trauma: a 5-year follow-up of an initial study of 10 patients","volume":"17","author":"Frudinger","year":"2015","journal-title":"Color. Dis."},{"key":"10.1016\/j.addr.2026.115859_bb0570","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1464-410X.2007.07119.x","article-title":"Autologous myoblasts and fibroblasts for female stress incontinence: a 1-year follow-up in 123 patients","volume":"100","author":"Mitterberger","year":"2007","journal-title":"BJU Int."},{"key":"10.1016\/j.addr.2026.115859_bb0575","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.juro.2007.08.154","article-title":"Myoblast and fibroblast therapy for post-prostatectomy urinary incontinence: 1-year follow-up of 63 patients","volume":"179","author":"Mitterberger","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0580","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.eururo.2007.07.026","article-title":"Adult stem cell therapy of female stress urinary incontinence","volume":"53","author":"Mitterberger","year":"2008","journal-title":"Eur. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0585","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s00192-007-0553-z","article-title":"1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence","volume":"19","author":"Carr","year":"2008","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.addr.2026.115859_bb0590","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00192-010-1255-5","article-title":"Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study","volume":"22","author":"S\u00e8be","year":"2011","journal-title":"Int. Urogynecol. J."},{"key":"10.1016\/j.addr.2026.115859_bb0595","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ijgo.2011.11.029","article-title":"Intrasphincteric autologous myoblast injections with electrical stimulation for stress urinary incontinence","volume":"117","author":"Blaganje","year":"2012","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.addr.2026.115859_bb0600","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.juro.2012.09.028","article-title":"Autologous muscle derived cell therapy for stress urinary incontinence: a prospective, dose ranging study","volume":"189","author":"Carr","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0605","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.juro.2014.02.047","article-title":"Autologous muscle derived cells for treatment of stress urinary incontinence in women","volume":"192","author":"Peters","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0610","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/nau.22404","article-title":"Autologous muscle-derived cells for the treatment of female stress urinary incontinence: a 2-year follow-up of a polish investigation","volume":"33","author":"Stangel-Wojcikiewicz","year":"2014","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.addr.2026.115859_bb0615","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/iju.13097","article-title":"Effect of autologous muscle-derived cells in the treatment of urinary incontinence in female patients with intrinsic sphincter deficiency and epispadias: a prospective study","volume":"23","author":"Sharifiaghdas","year":"2016","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0620","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1007\/s11255-018-2005-8","article-title":"A double-blind, randomized, placebo-controlled clinical trial evaluating the safety and efficacy of autologous muscle derived cells in female subjects with stress urinary incontinence","volume":"50","author":"Jankowski","year":"2018","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.addr.2026.115859_bb0625","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/nprot.2008.142","article-title":"Isolation of a slowly adhering cell fraction containing stem cells from murine skeletal muscle by the preplate technique","volume":"3","author":"Gharaibeh","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.addr.2026.115859_bb0630","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1002\/nau.25588","article-title":"Iltamiocel autologous cell therapy for the treatment of female stress urinary incontinence: a double-blind, randomized, stratified, placebo-controlled trial","volume":"43","author":"Kaufman","year":"2024","journal-title":"Neurourol.Urodyn."},{"key":"10.1016\/j.addr.2026.115859_bb0635","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/SLA.0000000000005894","article-title":"Safety and efficacy of Iltamiocel cellular therapy for the treatment of fecal incontinence. Results of a phase 1\/2 study","volume":"278","author":"Knowles","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.addr.2026.115859_bb0640","first-page":"127","article-title":"Novel murine xenograft model for the evaluation of stem cell therapy for profound dysphagia","author":"Kuhn","year":"2017","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2026.115859_bb0645","doi-asserted-by":"crossref","first-page":"E20","DOI":"10.1002\/lary.24352","article-title":"Autologous myoblasts attenuate atrophy and improve tongue force in a denervated tongue model: a pilot study","volume":"124","author":"Plowman","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2026.115859_bb0650","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/lary.29606","article-title":"Autologous muscle-derived cell therapy for swallowing impairment in patients following treatment for head and neck cancer","volume":"132","author":"Nativ-Zeltzer","year":"2022","journal-title":"Laryngoscope"},{"key":"10.1016\/j.addr.2026.115859_bb0655","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cgh.2022.07.039","article-title":"Skeletal muscle\u2013derived cell implantation for the treatment of fecal incontinence: a randomized, placebo-controlled study","volume":"21","author":"Frudinger","year":"2023","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2026.115859_bb0660","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/ijgo.13853","article-title":"The effect of skeletal muscle-derived cells implantation on stress urinary incontinence and functional urethral properties in female patients","volume":"157","author":"Blaganje","year":"2022","journal-title":"Int. J. Gynecol. Obstet."},{"key":"10.1016\/j.addr.2026.115859_bb0665","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/biom14050575","article-title":"Chimeric cell therapies as a novel approach for Duchenne muscular dystrophy (DMD) and muscle regeneration","volume":"14","author":"Budzynska","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.addr.2026.115859_bb0670","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s12015-018-9807-z","article-title":"Dystrophin expressing chimeric (DEC) human cells provide a potential therapy for Duchenne muscular dystrophy","volume":"14","author":"Siemionow","year":"2018","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0675","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s00018-025-05904-5","article-title":"Cell therapy for Duchenne muscular dystrophy: promises, challenges, and controversies","volume":"82","author":"\u0141oboda","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.addr.2026.115859_bb0680","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1007\/s12015-022-10384-2","article-title":"Long-term protective effect of human dystrophin expressing chimeric (DEC) cell therapy on amelioration of function of cardiac, respiratory and skeletal muscles in Duchenne muscular dystrophy","volume":"18","author":"Siemionow","year":"2022","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0685","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1007\/s12015-023-10620-3","article-title":"Safety and efficacy of DT-DEC01 therapy in Duchenne muscular dystrophy patients: a 12 - month follow-up study after systemic intraosseous administration","volume":"19","author":"Siemionow","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0690","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1007\/s12015-023-10530-4","article-title":"Dystrophin expressing chimeric (DEC) cell therapy for Duchenne muscular dystrophy: a first-in-human study with minimum 6 months follow-up","volume":"19","author":"Heydemann","year":"2023","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0695","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI63992","article-title":"Human satellite cells have regenerative capacity and are genetically manipulable","volume":"124","author":"Marg","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2026.115859_bb0700","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/ame2.12280","article-title":"Human primary muscle stem cells regenerate injured urethral sphincter in athymic rats","volume":"5","author":"Bekele","year":"2022","journal-title":"Animal Model Exp Med"},{"key":"10.1016\/j.addr.2026.115859_bb0705","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.omtn.2023.02.005","article-title":"Cas9-induced single cut enables highly efficient and template-free repair of a muscular dystrophy causing founder mutation","volume":"31","author":"M\u00fcthel","year":"2023","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.addr.2026.115859_bb0710","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41467-024-55086-0","article-title":"Gene-editing in patient and humanized-mice primary muscle stem cells rescues dysferlin expression in dysferlin-deficient muscular dystrophy","volume":"16","author":"Escobar","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.addr.2026.115859_bb0715","first-page":"2","article-title":"Prevention of muscle aging by myofiber-associated satellite cell transplantation","author":"Hall","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0720","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.juro.2007.02.044","article-title":"Intraurethral transfer of satellite cells by myofiber implants results in the formation of innervated myotubes exerting tonic contractions","volume":"178","author":"Lecoeur","year":"2007","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0725","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.stemcr.2015.07.016","article-title":"Human satellite cell transplantation and regeneration from diverse skeletal muscles","volume":"5","author":"Xu","year":"2015","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0730","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.juro.2014.04.005","article-title":"Intraurethral injection of autologous minced skeletal muscle: a simple surgical treatment for stress urinary incontinence","volume":"192","author":"Gr\u00e4s","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.addr.2026.115859_bb0735","doi-asserted-by":"crossref","DOI":"10.1002\/term.2873","article-title":"Use of uniformly sized muscle fiber fragments for restoration of muscle tissue function","author":"Ko","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0740","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1126\/science.1082254","article-title":"Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts","volume":"301","author":"Sampaolesi","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.addr.2026.115859_bb0745","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nature05282","article-title":"Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs","volume":"444","author":"Sampaolesi","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.addr.2026.115859_bb0750","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003541","article-title":"Transplantation of genetically corrected human iPSC-derived progenitors in mice with limb-girdle muscular dystrophy","volume":"4","author":"Tedesco","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0755","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1038\/cddis.2010.35","article-title":"Partial dysferlin reconstitution by adult murine mesoangioblasts is sufficient for full functional recovery in a murine model of dysferlinopathy","volume":"1","author":"D\u00edaz-Manera","year":"2010","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.addr.2026.115859_bb0760","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13395-015-0055-5","article-title":"Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A","volume":"5","author":"Domi","year":"2015","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.addr.2026.115859_bb0765","first-page":"3","article-title":"Stem cell\u2013mediated transfer of a human artificial chromosome ameliorates muscular dystrophy","author":"Tedesco","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0770","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ymthe.2018.01.021","article-title":"Autologous cell therapy approach for Duchenne muscular dystrophy using PiggyBac transposons and mesoangioblasts","volume":"26","author":"Iyer","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0775","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2217\/17460751.2.3.275","article-title":"Multipotential mesoangioblast stem cell therapy in the Mdx\/Utrn -\/- mouse model for Duchenne muscular dystrophy","volume":"2","author":"Berry","year":"2007","journal-title":"Regen. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0780","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.15252\/emmm.201505636","article-title":"Intra-arterial transplantation of HLA -matched donor mesoangioblasts in Duchenne muscular dystrophy","volume":"7","author":"Cossu","year":"2015","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.addr.2026.115859_bb0785","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s44321-024-00031-3","article-title":"Cell-mediated exon skipping normalizes dystrophin expression and muscle function in a new mouse model of Duchenne muscular dystrophy","volume":"16","author":"Galli","year":"2024","journal-title":"EMBO Mol. Med."},{"issue":"10","key":"10.1016\/j.addr.2026.115859_bb0790","doi-asserted-by":"crossref","first-page":"5061","DOI":"10.1016\/j.ymthe.2025.07.005","article-title":"Intra-arterial transplantation of autologous mesoangioblasts in m.3243A>G mutation carriers is safe: first phase 1\/2 human clinical study","volume":"33","author":"van Tienen","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0795","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/s13287-019-1510-8","article-title":"Healthy, mtDNA-mutation free mesoangioblasts from mtDNA patients qualify for autologous therapy","volume":"10","author":"van Tienen","year":"2019","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0800","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.stem.2020.09.014","article-title":"Pluripotent stem cell-based cell therapy\u2014promise and challenges","volume":"27","author":"Yamanaka","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0805","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.stemcr.2023.03.005","article-title":"History and current status of clinical studies using human pluripotent stem cells","volume":"18","author":"Kobold","year":"2023","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.addr.2026.115859_bb0810","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.stem.2025.01.003","article-title":"Pluripotent stem-cell-derived therapies in clinical trial: a 2025 update","volume":"32","author":"Kirkeby","year":"2025","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0815","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.stem.2012.02.015","article-title":"Human ES- and iPS-derived myogenic progenitors restore DYSTROPHIN and improve contractility upon transplantation in dystrophic mice","volume":"10","author":"Darabi","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0820","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s13395-020-00228-3","article-title":"Efficient engraftment of pluripotent stem cell-derived myogenic progenitors in a novel immunodeficient mouse model of limb girdle muscular dystrophy 2I","volume":"10","author":"Azzag","year":"2020","journal-title":"Skelet. Muscle"},{"key":"10.1016\/j.addr.2026.115859_bb0825","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1016\/j.celrep.2017.06.005","article-title":"PAX7 targets, CD54, integrin \u03b19\u03b21, and SDC2, allow isolation of human ESC\/iPSC-derived myogenic progenitors","volume":"19","author":"Magli","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0830","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109360","article-title":"A universal gene correction approach for FKRP-associated dystroglycanopathies to enable autologous cell therapy","volume":"36","author":"Dhoke","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0835","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/j.ymthe.2019.08.011","article-title":"Gene correction of LGMD2A patient-specific iPSCs for the development of targeted autologous cell therapy","volume":"27","author":"Selvaraj","year":"2019","journal-title":"Mol. Ther."},{"issue":"10","key":"10.1016\/j.addr.2026.115859_bb0840","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1016\/j.ymthe.2025.07.007","article-title":"Preclinical quality, safety, and efficacy of a CGMP iPSC-derived myogenic progenitor product for the treatment of muscular dystrophies","volume":"33","author":"Azzag","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.addr.2026.115859_bb0845","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1161\/CIRCRESAHA.109.210682","article-title":"Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice","volume":"106","author":"Chimenti","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.addr.2026.115859_bb0850","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/stem.532","article-title":"Cardiospheres recapitulate a niche-like microenvironment rich in stemness and cell-matrix interactions, rationalizing their enhanced functional potency for myocardial repair","volume":"28","author":"Li","year":"2010","journal-title":"Stem Cells"},{"key":"10.1016\/j.addr.2026.115859_bb0855","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.addr.2026.115859_bb0860","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.stemcr.2018.01.023","article-title":"Exosome-mediated benefits of cell therapy in mouse and human models of Duchenne muscular dystrophy","volume":"10","author":"Aminzadeh","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.addr.2026.115859_bb0865","first-page":"4","article-title":"Disease-modifying bioactivity of intravenous cardiosphere-derived cells and exosomes in mdx mice. JCI","author":"Rogers","year":"2019","journal-title":"Insight"},{"key":"10.1016\/j.addr.2026.115859_bb0870","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim","year":"2014","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.addr.2026.115859_bb0875","first-page":"92","article-title":"Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial","author":"Taylor","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115859_bb0880","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(22)00012-5","article-title":"Repeated intravenous cardiosphere-derived cell therapy in late-stage Duchenne muscular dystrophy (HOPE-2): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"399","author":"McDonald","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2026.115859_bb0885","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s12015-010-9187-5","article-title":"Human multipotent mesenchymal stromal cells from distinct sources show different in vivo potential to differentiate into muscle cells when injected in dystrophic mice","volume":"6","author":"Vieira","year":"2010","journal-title":"Stem Cell Rev. Rep."},{"key":"10.1016\/j.addr.2026.115859_bb0890","article-title":"Intravenous administration of umbilical cord lining stem cells in left ventricular assist device recipients: results of the uSTOP LVAD BLEED pilot study","volume":"3","author":"Ahmed","year":"2024","journal-title":"JHLT"},{"key":"10.1016\/j.addr.2026.115859_bb0895","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.3727\/096368910X514260","article-title":"An efficient approach to isolation and characterization of pre- and postnatal umbilical cord lining stem cells for clinical applications","volume":"19","author":"Gonzalez","year":"2010","journal-title":"Cell Transplant."},{"key":"10.1016\/j.addr.2026.115859_bb0900","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3988\/jcn.2024.0299","article-title":"Safety and tolerability of Wharton\u2019s jelly-derived mesenchymal stem cells for patients with Duchenne muscular dystrophy: a phase 1 clinical study","volume":"21","author":"Lee","year":"2025","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.addr.2026.115859_bb0905","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.stemcr.2023.05.017","article-title":"Unproven cell interventions in Poland and the exploitation of European Union law on advanced therapy medicinal products","volume":"18","author":"Dulak","year":"2023","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.addr.2026.115859_bb0910","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.42.12.2258","article-title":"Arterial delivery of myoblasts to skeletal muscle","volume":"42","author":"Neumeyer","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.addr.2026.115859_bb0915","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/518135","article-title":"Potential and limitation of HLA-based banking of human pluripotent stem cells for cell therapy","volume":"2014","author":"de Rham","year":"2014","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.addr.2026.115859_bb0920","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","article-title":"Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types","volume":"11","author":"Taylor","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0925","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.stem.2013.08.003","article-title":"Toward the development of a global induced pluripotent stem cell library","volume":"13","author":"Turner","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.addr.2026.115859_bb0930","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.stemcr.2015.08.015","article-title":"cGMP-manufactured human induced pluripotent stem cells are available for pre-clinical and clinical applications","volume":"5","author":"Baghbaderani","year":"2015","journal-title":"Stem Cell Reports"},{"key":"10.1016\/j.addr.2026.115859_bb0935","first-page":"4","article-title":"iPSC modification strategies to induce immune tolerance","author":"Hong","year":"2025","journal-title":"Life Medicine"}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X26000931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T21:14:09Z","timestamp":1776114849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X26000931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":187,"alternative-id":["S0169409X26000931"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2026.115859","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progress on cell therapy for skeletal muscle disorders","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2026.115859","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115859"}}